{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:02:00Z","timestamp":1789977720663,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00203-026-05184-y","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:07:57Z","timestamp":1789974477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silybum marianum against multidrug-resistant bacterial pathogens: mechanisms of action, synergistic therapy, nanoformulations, and clinical translation"],"prefix":"10.1007","volume":"208","author":[{"given":"Syed Suhaib","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaswati","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punitha","family":"Muruganantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marakanam Srinivasan","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-1776","authenticated-orcid":false,"given":"Inamul Hasan","family":"Madar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"10","key":"5184_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105420","volume":"23","author":"AS Abdullah","year":"2022","unstructured":"Abdullah AS, Sayed IETE, El-Torgoman AMA, Kalam A, Wageh S, Kamel MA (2022) Green synthesis of silymarin\u2013chitosan nanoparticles as a new nano formulation with enhanced anti-fibrotic effects against liver fibrosis. Int J Mol Sci 23(10):5420. https:\/\/doi.org\/10.3390\/ijms23105420","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5184_CR2","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","volume":"32","author":"L Abenavoli","year":"2018","unstructured":"Abenavoli L, Izzo AA, Mili\u0107 N, Cicala C, Santini A, Capasso R (2018) Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res 32(11):2202\u20132213. https:\/\/doi.org\/10.1002\/ptr.6171","journal-title":"Phytother Res"},{"issue":"11","key":"5184_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.52403\/ijrr.20231132","volume":"10","author":"Y Agrawal","year":"2023","unstructured":"Agrawal Y, Goyal MK (2023) Development and in vitro evaluation of nanoparticles of silymarin using central composite design. Int J Res Rev 10(11):269\u2013280. https:\/\/doi.org\/10.52403\/ijrr.20231132","journal-title":"Int J Res Rev"},{"issue":"4","key":"5184_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/0975-7406.168037","volume":"7","author":"S Ahmad","year":"2015","unstructured":"Ahmad S, Parveen R, Baboota S, Ali J, Ahuja A (2015) Stability studies of silymarin nanoemulsion containing Tween 80 as a surfactant. J Pharm Bioallied Sci 7(4):321\u2013328. https:\/\/doi.org\/10.4103\/0975-7406.168037","journal-title":"J Pharm Bioallied Sci"},{"issue":"1","key":"5184_CR5","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1080\/10942912.2023.2244685","volume":"26","author":"MN Akhtar","year":"2023","unstructured":"Akhtar MN, Saeed R, Saeed F, Asghar A, Ghani S, Ateeq H et al (2023) Silymarin: a review on paving the way towards promising pharmacological agent. Int J Food Prop 26(1):2256\u20132272. https:\/\/doi.org\/10.1080\/10942912.2023.2244685","journal-title":"Int J Food Prop"},{"issue":"3","key":"5184_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1166\/sam.2024.4632","volume":"16","author":"HA Albarqi","year":"2024","unstructured":"Albarqi HA, Ahmad MZ, Albekairi TH, Alqhamdi EM, Albawardi SS, Ahmad J, Alshahrani RS, Algahtani MS, Alqahtani AA, Alasiri A, Walbi IA (2024) Investigating the wound healing activity of silymarin nanoemulsion loaded in chitosan gel. Sci Adv Mater 16(3):357\u2013366. https:\/\/doi.org\/10.1166\/sam.2024.4632","journal-title":"Sci Adv Mater"},{"issue":"9","key":"5184_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/antibiotics9090562","volume":"9","author":"HA Alhadrami","year":"2020","unstructured":"Alhadrami HA, Hamed AA, Hassan HM, Belbahri L, Rateb ME, Sayed AM (2020) Flavonoids as potential anti-MRSA agents through modulation of PBP2a: a computational and experimental study. Antibiotics (Basel, Switzerland) 9(9):562. https:\/\/doi.org\/10.3390\/antibiotics9090562","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"5","key":"5184_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.26655\/JMCHEMSCI.2023.5.21","volume":"6","author":"S Al-Musawi","year":"2023","unstructured":"Al-Musawi S et al (2023) Activity of Silybum marianum in oral candidiasis of albino rats. J Med Chem Sci 6(5):1144\u20131152. https:\/\/doi.org\/10.26655\/JMCHEMSCI.2023.5.21","journal-title":"J Med Chem Sci"},{"issue":"4","key":"5184_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/su15043126","volume":"15","author":"Y Anwar","year":"2023","unstructured":"Anwar Y, Khan SU, Ullah I, Hemeg HA, Ashamrani R, Al-sulami N et al (2023) Molecular identification of endophytic bacteria from Silybum marianum and their effect on Brassica napus growth under heavy metal stress. Sustainability (Basel) 15(4):3126. https:\/\/doi.org\/10.3390\/su15043126","journal-title":"Sustainability (Basel)"},{"issue":"1\u20132","key":"5184_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijpharm.2005.10.029","volume":"308","author":"TC Bai","year":"2006","unstructured":"Bai TC, Yan GB, Hu J, Zhang HL, Huang CG (2006) Solubility of silybin in aqueous poly(ethylene glycol) solution. Int J Pharm 308(1\u20132):100\u2013106. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.029","journal-title":"Int J Pharm"},{"issue":"5","key":"5184_CR11","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/jsfa.14045","volume":"105","author":"T Bencsik","year":"2025","unstructured":"Bencsik T, Bal\u00e1zs O, Vida RG, Zsid\u00f3 BZ, Het\u00e9nyi C, Valentov\u00e1 K et al (2025) Effects of catechins, resveratrol, silymarin components and some of their conjugates on xanthine oxidase\u2010catalyzed xanthine and 6\u2010mercaptopurine oxidation. J Sci Food Agric 105(5):2765\u20132776. https:\/\/doi.org\/10.1002\/jsfa.14045","journal-title":"J Sci Food Agric"},{"issue":"11","key":"5184_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22111942","volume":"22","author":"M Bijak","year":"2017","unstructured":"Bijak M (2017) Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.)-chemistry, bioavailability, and metabolism. Molecules 22(11):1942. https:\/\/doi.org\/10.3390\/molecules22111942","journal-title":"Molecules"},{"key":"5184_CR13","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/IJN.S48037","volume":"8","author":"HG Choi","year":"2013","unstructured":"Choi HG, Yong CS, Yang KY, Hwang DH, Kim DW, Bae ON et al (2013) Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation. Int J Nanomedicine 8:3333\u20133343. https:\/\/doi.org\/10.2147\/IJN.S48037","journal-title":"Int J Nanomedicine"},{"issue":"07","key":"5184_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.36349\/easjms.2024.v07i07.001","volume":"7","author":"T Datta","year":"2024","unstructured":"Datta T, Chaudhuri BN, Guchhait P, Dawn AK, Das S (2024) Antimicrobial effect of Cinnamomum verum leaf extract on fungus and MDR bacteria. East African Scholars J Med Sci 7(07):259\u2013267. https:\/\/doi.org\/10.36349\/easjms.2024.v07i07.001","journal-title":"East African Scholars J Med Sci"},{"key":"5184_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/292797","author":"DR De Oliveira","year":"2015","unstructured":"De Oliveira DR, Tintino SR, Morais Braga MFB, Boligon AA, Linde Athayde M, Douglas Melo Coutinho H et al (2015) In vitro antimicrobial and modulatory activity of the natural products silymarin and silibinin. BioMed Res Int. https:\/\/doi.org\/10.1155\/2015\/292797","journal-title":"BioMed Res Int"},{"issue":"2","key":"5184_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom9020056","volume":"9","author":"ML Del Prado-Audelo","year":"2019","unstructured":"Del Prado-Audelo ML, Caballero-Flor\u00e1n IH, Meza-Toledo JA, Mendoza-Mu\u00f1oz N, Gonz\u00e1lez-Torres M, Flor\u00e1n B, Cort\u00e9s H, Leyva-G\u00f3mez G (2019) Formulations of curcumin nanoparticles for brain diseases. Biomolecules 9(2):56. https:\/\/doi.org\/10.3390\/biom9020056","journal-title":"Biomolecules"},{"issue":"11","key":"5184_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24112155","volume":"24","author":"A Di Costanzo","year":"2019","unstructured":"Di Costanzo A, Angelico R (2019) Formulation strategies for enhancing the bioavailability of silymarin: the state of the art. Molecules 24(11):2155. https:\/\/doi.org\/10.3390\/molecules24112155","journal-title":"Molecules"},{"issue":"4","key":"5184_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/0253-7613.36534","volume":"39","author":"N Dixit","year":"2007","unstructured":"Dixit N, Baboota S, Kohli K, Ahmad S, Ali J (2007) Silymarin: a review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol 39(4):172\u2013179. https:\/\/doi.org\/10.4103\/0253-7613.36534","journal-title":"Indian J Pharmacol"},{"issue":"1\u20132","key":"5184_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijpharm.2005.11.006","volume":"308","author":"MS El-Samaligy","year":"2006","unstructured":"El-Samaligy MS, Afifi NN, Mahmoud EA (2006) Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308(1\u20132):140\u2013148. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.11.006","journal-title":"Int J Pharm"},{"issue":"1","key":"5184_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29010064","volume":"29","author":"S El-Sapagh","year":"2023","unstructured":"El-Sapagh S, Allam NG, El-Sayed MNED, El-Hefnawy AA, Korbecka-Glinka G, Shala AY (2023) Effects of Silybum marianum L. seed extracts on multi drug resistant (MDR) bacteria. Molecules 29(1):64. https:\/\/doi.org\/10.3390\/molecules29010064","journal-title":"Molecules"},{"key":"5184_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.intimp.2017.06.030","volume":"50","author":"N Esmaeil","year":"2017","unstructured":"Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B (2017) Silymarin impacts on immune system as an immunomodulator: one key for many locks. Int Immunopharmacol 50:194\u2013201. https:\/\/doi.org\/10.1016\/j.intimp.2017.06.030","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"5184_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24081547","volume":"24","author":"T Esposito","year":"2019","unstructured":"Esposito T, Sansone F, Russo P, Picerno P, Aquino RP, Gasparri F et al (2019) A water-soluble microencapsulated milk thistle extract as active ingredient for dermal formulations. Molecules 24(8):1547. https:\/\/doi.org\/10.3390\/molecules24081547","journal-title":"Molecules"},{"issue":"4","key":"5184_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12223-015-0399-6","volume":"60","author":"E Evren","year":"2015","unstructured":"Evren E, Yurtcu E (2015) In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol (Praha) 60(4):351\u2013356. https:\/\/doi.org\/10.1007\/s12223-015-0399-6","journal-title":"Folia Microbiol (Praha)"},{"issue":"2","key":"5184_CR24","first-page":"627","volume":"14","author":"Z Faezizadeh","year":"2015","unstructured":"Faezizadeh Z, Gharib A, Godarzee M (2015) In-vitro and in-vivo evaluation of silymarin nanoliposomes against isolated methicillin-resistant Staphylococcus aureus. Iran J Pharm Res 14(2):627\u2013633","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"5184_CR25","first-page":"89","volume":"37","author":"M Faizan","year":"2024","unstructured":"Faizan M (2024) Formulation design and characterization of silymarin liposomes for enhanced antitumor activity. Pakistan J Pharm Sci 37(1):89\u201396","journal-title":"Pakistan J Pharm Sci"},{"issue":"2","key":"5184_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22020191","volume":"22","author":"A Federico","year":"2017","unstructured":"Federico A, Dallio M, Loguercio C (2017) Silymarin\/silybin and chronic liver disease: a marriage of many years. Molecules 22(2):191. https:\/\/doi.org\/10.3390\/molecules22020191","journal-title":"Molecules"},{"key":"5184_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02549-18","author":"RK Flamm","year":"2019","unstructured":"Flamm RK, Rhomberg PR, Lindley JM, Sweeney K, Ellis-Grosse EJ, Shortridge D (2019) Evaluation of the bactericidal activity of fosfomycin in combination with selected comparison agents tested against Gram-negative bacterial strains by using time-kill curves. Antimicro Agents Chemotherap. https:\/\/doi.org\/10.1128\/AAC.02549-18","journal-title":"Antimicro Agents Chemotherap"},{"issue":"6","key":"5184_CR28","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2017.10.012","volume":"171","author":"E Garc\u00eda-Fern\u00e1ndez","year":"2017","unstructured":"Garc\u00eda-Fern\u00e1ndez E, Koch G, Wagner RM, Fekete A, Stengel ST, Schneider J, Mielich-S\u00fcss B, Geibel S, Markert SM, Stigloher C, Lopez D (2017) Membrane microdomain disassembly inhibits MRSA antibiotic resistance. Cell 171(6):1354-1367.e20. https:\/\/doi.org\/10.1016\/j.cell.2017.10.012","journal-title":"Cell"},{"issue":"3","key":"5184_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcpt.12088","volume":"113","author":"M Gharagozloo","year":"2013","unstructured":"Gharagozloo M, Jafari S, Esmaeil N, Javid EN, Bagherpour B, Rezaei A (2013) Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production. Basic Clin Pharmacol Toxicol 113(3):209\u2013214. https:\/\/doi.org\/10.1111\/bcpt.12088","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"5184_CR30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","volume":"37","author":"A Gillessen","year":"2020","unstructured":"Gillessen A, Schmidt HHJ (2020) Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther 37(4):1279\u20131301. https:\/\/doi.org\/10.1007\/s12325-020-01251-y","journal-title":"Adv Ther"},{"issue":"1","key":"5184_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37350-3","volume":"13","author":"B Haghshenas","year":"2023","unstructured":"Haghshenas B, Kiani A, Mansoori S, Mohammadi-noori E, Nami Y (2023) Probiotic properties and antimicrobial evaluation of silymarin-enriched Lactobacillus bacteria isolated from traditional curd. Sci Rep 13(1):Article 10834. https:\/\/doi.org\/10.1038\/s41598-023-37350-3","journal-title":"Sci Rep"},{"key":"5184_CR32","unstructured":"Chinese Patent No. CN101164537B. (2008). High-efficient oral silibinin sustained-release preparation and preparation method thereof. Google Patents. https:\/\/patents.google.com\/patent\/CN101164537B\/en"},{"issue":"3","key":"5184_CR33","first-page":"239","volume":"16","author":"S Javed","year":"2011","unstructured":"Javed S, Kohli K, Ali M (2011) Reassessing bioavailability of silymarin. Altern Med Rev 16(3):239\u2013249","journal-title":"Altern Med Rev"},{"issue":"1","key":"5184_CR34","first-page":"9","volume":"8","author":"S Javed","year":"2016","unstructured":"Javed S, Kohli K, Ahsan W (2016) Solubility and dissolution enhancement of silymarin with fulvic acid carrier. Int J Drug Dev Res 8(1):9\u201314","journal-title":"Int J Drug Dev Res"},{"key":"5184_CR35","doi-asserted-by":"publisher","DOI":"10.23880\/beba-16000120","author":"S Javed","year":"2018","unstructured":"Javed S, Kohli K, Ahsan W (2018) Enhanced intestinal permeability of silymarin by natural products as bioenhancers - Assessment by ex-vivo non-everted rat gut sac study. Bioequiv Bioavailab Int J. https:\/\/doi.org\/10.23880\/beba-16000120","journal-title":"Bioequiv Bioavailab Int J"},{"key":"5184_CR36","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902022000119323","author":"S Javed","year":"2022","unstructured":"Javed S, Kohli K, Ahsan W (2022) Bioavailability augmentation of silymarin using natural bioenhancers: An in vivo pharmacokinetic study. Braz J Pharm Sci. https:\/\/doi.org\/10.1590\/s2175-97902022000119323","journal-title":"Braz J Pharm Sci"},{"issue":"2","key":"5184_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0031-2018","volume":"7","author":"C Jenul","year":"2019","unstructured":"Jenul C, Horswill AR (2019) Regulation of Staphylococcus aureus virulence. Microbiol Spectr 7(2):10.1128\/microbiolspec.gpp3-0031-2018. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0031-2018","journal-title":"Microbiol Spectr"},{"issue":"11","key":"5184_CR38","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/biot.201000422","volume":"6","author":"H Kang","year":"2011","unstructured":"Kang H, Kim H, Cha J (2011) Synergistic effects between silibinin and antibiotics on methicillin\u2010resistant Staphylococcus aureus isolated from clinical specimens. Biotechnol J 6(11):1397\u20131408. https:\/\/doi.org\/10.1002\/biot.201000422","journal-title":"Biotechnol J"},{"key":"5184_CR39","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.indcrop.2011.03.027","volume":"34","author":"A Karkanis","year":"2011","unstructured":"Karkanis A, Bilalis D, Efthimiadou A (2011) Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Ind Crops Prod 34:825\u2013830. https:\/\/doi.org\/10.1016\/j.indcrop.2011.03.027","journal-title":"Ind Crops Prod"},{"issue":"4","key":"5184_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","volume":"3","author":"K Kesarwani","year":"2013","unstructured":"Kesarwani K, Gupta R (2013) Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed 3(4):253\u2013266. https:\/\/doi.org\/10.1016\/S2221-1691(13)60060-X","journal-title":"Asian Pac J Trop Biomed"},{"issue":"5","key":"5184_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1099\/jmm.0.036939-0","volume":"61","author":"J-Y Kim","year":"2012","unstructured":"Kim J-Y, Peck KR, Kim MJ, Choi JY, Kim HS, Kim SH, Ko KS (2012) In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates. J Med Microbiol 61(5):681\u2013689. https:\/\/doi.org\/10.1099\/jmm.0.036939-0","journal-title":"J Med Microbiol"},{"issue":"3","key":"5184_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5530\/ijpi.2022.3.53","volume":"12","author":"M Kumar Singh","year":"2022","unstructured":"Kumar Singh M, Patil UK (2022) Development and characterization of silymarin phospholipid complex for improved solubility, and toxicological evaluation in experimental animals. Int J Pharm Investig 12(3):299\u2013316. https:\/\/doi.org\/10.5530\/ijpi.2022.3.53","journal-title":"Int J Pharm Investig"},{"issue":"12","key":"5184_CR43","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.4014\/jmb.1710.10029","volume":"27","author":"B Lee","year":"2017","unstructured":"Lee B, Lee DG (2017) Reactive oxygen species depletion by silibinin stimulates apoptosis-like death in Escherichia coli. J Microbiol Biotechnol 27(12):2129\u20132140. https:\/\/doi.org\/10.4014\/jmb.1710.10029","journal-title":"J Microbiol Biotechnol"},{"key":"5184_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/618081","author":"YS Lee","year":"2012","unstructured":"Lee YS, Jang KA, Cha JD (2012) Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria. J Biomed Biotechnol. https:\/\/doi.org\/10.1155\/2012\/618081","journal-title":"J Biomed Biotechnol"},{"key":"5184_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/metabolites15010013","author":"S Lekmine","year":"2025","unstructured":"Lekmine S, Benslama O, Ola MS, Touzout N, Moussa H, Tahraoui H et al (2025) Preliminary data on Silybum marianum metabolites: Comprehensive characterization, antioxidant, antidiabetic, antimicrobial activities, LC-MS\/MS profiling, and predicted ADMET analysis. Metabolites. https:\/\/doi.org\/10.3390\/metabolites15010013","journal-title":"Metabolites"},{"issue":"11","key":"5184_CR46","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1039\/c5fo00899a","volume":"6","author":"K Liao","year":"2015","unstructured":"Liao K, He F, Chi S, Zhang K (2015) Potent inhibitory effect of silibinin from milk thistle on skin inflammation stimuli by 12-O-tetradecanoylphorbol-13-acetate. Food Funct 6(11):3706\u20133715. https:\/\/doi.org\/10.1039\/c5fo00899a","journal-title":"Food Funct"},{"key":"5184_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.mib.2017.02.001","volume":"36","author":"D Lopez","year":"2017","unstructured":"Lopez D, Koch G (2017) Exploring functional membrane microdomains in bacteria: an overview. Curr Opin Microbiol 36:76\u201384. https:\/\/doi.org\/10.1016\/j.mib.2017.02.001","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"5184_CR48","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1039\/d2ra06696c","volume":"13","author":"X Lu","year":"2023","unstructured":"Lu X, Wang G, Xie Y, Tang W, Liu B, Zhang J (2023) Efflux pump inhibitor combined with ofloxacin decreases MRSA biofilm formation by regulating the gene expression of NorA and quorum sensing. RSC Adv 13(4):2707\u20132717. https:\/\/doi.org\/10.1039\/d2ra06696c","journal-title":"RSC Adv"},{"issue":"18","key":"5184_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/app14188477","volume":"14","author":"S Makouie","year":"2024","unstructured":"Makouie S, Bry\u015b J, Ma\u0142ajowicz J, Koczo\u0144 P, Siol M, Palani BK et al (2024) A comprehensive review of silymarin extraction and liposomal encapsulation techniques for potential applications in food. Appl Sci 14(18):8477. https:\/\/doi.org\/10.3390\/app14188477","journal-title":"Appl Sci"},{"issue":"10","key":"5184_CR50","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.18203\/2394-6040.ijcmph20233126","volume":"10","author":"AM Malki","year":"2023","unstructured":"Malki AM, Alaeq RA, Alosaimi AA, Ageeli MM, Alshehri GM, Shati RO (2023) Antibiotic synergy as a strategy for combating multidrug-resistant bacteria: A review of mechanisms and clinical implications. Int J Commun Med Public Health 10(10):3885\u20133890. https:\/\/doi.org\/10.18203\/2394-6040.ijcmph20233126","journal-title":"Int J Commun Med Public Health"},{"issue":"3","key":"5184_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031514","volume":"28","author":"T Maryam","year":"2023","unstructured":"Maryam T, Rana NF, Alshahrani SM, Batool F, Fatima M, Tanweer T et al (2023) Silymarin encapsulated liposomal formulation: an effective treatment modality against copper toxicity associated liver dysfunction and neurobehavioral abnormalities in Wistar rats. Molecules 28(3):1514. https:\/\/doi.org\/10.3390\/molecules28031514","journal-title":"Molecules"},{"key":"5184_CR52","doi-asserted-by":"publisher","DOI":"10.2174\/1389200225666240619114221","author":"IA Najar","year":"2024","unstructured":"Najar IA, Pamu S, Paul A, Arora P, Kaur G, Kumar M (2024) WITHDRAWN: Pharmacokinetic drug interactions of piperine: A review of pre-clinical and clinical studies. Curr Drug Metabol. https:\/\/doi.org\/10.2174\/1389200225666240619114221","journal-title":"Curr Drug Metabol"},{"issue":"3","key":"5184_CR53","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/pr.111.005769","volume":"65","author":"EI Nielsen","year":"2013","unstructured":"Nielsen EI, Friberg LE (2013) Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs. Pharmacol Rev 65(3):1053\u20131090. https:\/\/doi.org\/10.1124\/pr.111.005769","journal-title":"Pharmacol Rev"},{"issue":"13\u201314","key":"5184_CR54","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","volume":"65","author":"RY Pelgrift","year":"2013","unstructured":"Pelgrift RY, Friedman AJ (2013) Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev 65(13\u201314):1803\u20131815. https:\/\/doi.org\/10.1016\/j.addr.2013.07.011","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"5184_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13111091","volume":"13","author":"JL Pereira-Filho","year":"2024","unstructured":"Pereira-Filho JL, Mendes AGG, Campos CDL, Moreira IV, Monteiro CRAV, Soczek SHDS et al (2024) A comprehensive review on the antibacterial, antifungal, antiviral, and antiparasitic potential of silybin. Antibiotics (Basel) 13(11):1091. https:\/\/doi.org\/10.3390\/antibiotics13111091","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"5184_CR56","first-page":"75","volume":"4","author":"MA Rahman","year":"2022","unstructured":"Rahman MA (2022) Silymarin loaded solid lipid nanoparticles for oral delivery: development, characterization and cytotoxic effect on breast cancer cells. Clin Trials Pract Phytother Chem 4(2):75\u201382","journal-title":"Clin Trials Pract Phytother Chem"},{"key":"5184_CR57","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/IJN.S227805","volume":"15","author":"HS Rahman","year":"2020","unstructured":"Rahman HS, Othman HH, Hammadi NI, Yeap SK, Amin KM, Abdul Samad N, Alitheen NB (2020) Novel drug delivery systems for loading of natural plant extracts and their biomedical applications. Int J Nanomedicine 15:2439\u20132483. https:\/\/doi.org\/10.2147\/IJN.S227805","journal-title":"Int J Nanomedicine"},{"issue":"35","key":"5184_CR58","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1021\/acs.jpcb.5b06448","volume":"119","author":"M Reina","year":"2015","unstructured":"Reina M, Mart\u00ednez A (2015) Silybin and 2,3-dehydrosilybin flavonolignans as free radical scavengers. J Phys Chem B 119(35):11597\u201311606. https:\/\/doi.org\/10.1021\/acs.jpcb.5b06448","journal-title":"J Phys Chem B"},{"issue":"4","key":"5184_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5958\/2231-5713.2017.00032.0","volume":"7","author":"IM Saiyyad","year":"2017","unstructured":"Saiyyad IM, Bhambere DS, Kshirsagar S (2017) Formulation and optimization of silymarin loaded PLGA nanoparticle for liver targeting. Asian J Pharm Tech 7(4):209\u2013220. https:\/\/doi.org\/10.5958\/2231-5713.2017.00032.0","journal-title":"Asian J Pharm Tech"},{"issue":"10","key":"5184_CR60","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.52711\/0974-360X.2021.00959","volume":"14","author":"S Saiyyad","year":"2021","unstructured":"Saiyyad S, Mandal P, Verma P (2021) Characterisation of preformulation parameters to design, develop and formulate silymarin loaded PLGA nanoparticles for liver targeted drug delivery. Res J Pharm Tech 14(10):5508\u20135514. https:\/\/doi.org\/10.52711\/0974-360X.2021.00959","journal-title":"Res J Pharm Tech"},{"issue":"20","key":"5184_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.47750\/jptcp.2023.30.20.007","volume":"30","author":"M Sher","year":"2023","unstructured":"Sher M, Hussain I, Gulfam N, Afridi HH, Sher WM, Ateeq M et al (2023) Enhanced antioxidant and antimicrobial activities of silymarin after particle size reduction to nanometer scale. J Pop Therap Clin Pharmacol 30(20):46\u201384. https:\/\/doi.org\/10.47750\/jptcp.2023.30.20.007","journal-title":"J Pop Therap Clin Pharmacol"},{"issue":"3","key":"5184_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.30466\/vrf.2018.83961.2105","volume":"11","author":"A Soltanian","year":"2020","unstructured":"Soltanian A, Mosallanejad B, Jalali MR, Varzi HN, Ghorbanpoor M (2020) Comparative evaluation of the therapeutic effects of silymarin and hydrocortisone on clinical and hematological alterations, and organ injury (liver and heart) in low-dose canine lipopolysaccharide-induced sepsis model. Vet Res Forum 11(3):235\u2013241. https:\/\/doi.org\/10.30466\/vrf.2018.83961.2105","journal-title":"Vet Res Forum"},{"issue":"4","key":"5184_CR63","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1166\/jbn.2014.1798","volume":"10","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhang L, Wang Q, Zhang D (2014) Recent advances in the nanotechnology-based drug delivery of silybin. J Biomed Nanotechnol 10(4):543\u2013558. https:\/\/doi.org\/10.1166\/jbn.2014.1798","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"5184_CR64","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3892\/mmr.2018.9021","volume":"18","author":"D Wang","year":"2018","unstructured":"Wang D, Xie K, Zou D, Meng M, Xie M (2018a) Inhibitory effects of silybin on the efflux pump of methicillin-resistant Staphylococcus aureus. Mol Med Rep 18(1):809\u2013814. https:\/\/doi.org\/10.3892\/mmr.2018.9021","journal-title":"Mol Med Rep"},{"issue":"1","key":"5184_CR65","first-page":"827","volume":"18","author":"D Wang","year":"2018","unstructured":"Wang D, Xie K, Zou D, Meng M, Xie M (2018b) Inhibitory effects of silybin on the efflux pump of methicillin-resistant Staphylococcus aureus. Mol Med Rep 18(1):827\u2013833","journal-title":"Mol Med Rep"},{"issue":"6","key":"5184_CR66","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/aps.2010.55","volume":"31","author":"JN Yu","year":"2010","unstructured":"Yu JN, Zhu Y, Wang L, Peng M, Tong SS, Cao X et al (2010) Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate\/phospholipid-mixed micelles. Acta Pharmacol Sin 31(6):759\u2013764. https:\/\/doi.org\/10.1038\/aps.2010.55","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"5184_CR67","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbamem.2017.01.009","volume":"1859","author":"DG Yun","year":"2017","unstructured":"Yun DG, Lee DG (2017) Silymarin exerts antifungal effects via membrane-targeted mode of action by increasing permeability and inducing oxidative stress. Biochimica Et Biophysica Acta (BBA) - Biomembranes 1859(3):467\u2013474. https:\/\/doi.org\/10.1016\/j.bbamem.2017.01.009","journal-title":"Biochimica Et Biophysica Acta (BBA) - Biomembranes"},{"issue":"6","key":"5184_CR68","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/jvp.12319","volume":"39","author":"A Zholobenko","year":"2016","unstructured":"Zholobenko A, Mouithys-Mickalad A, Modriansky M, Serteyn D, Franck T (2016) Polyphenols from Silybum marianum inhibit in vitro the oxidant response of equine neutrophils and myeloperoxidase activity. J Vet Pharmacol Ther 39(6):592\u2013601. https:\/\/doi.org\/10.1111\/jvp.12319","journal-title":"J Vet Pharmacol Ther"},{"key":"5184_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1000974","volume":"13","author":"YX Zhou","year":"2022","unstructured":"Zhou YX, Cao XY, Peng C (2022) Antimicrobial activity of natural products against MDR bacteria: a scientometric visualization analysis. Front Pharmacol 13:1000974. https:\/\/doi.org\/10.3389\/fphar.2022.1000974","journal-title":"Front Pharmacol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05184-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05184-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05184-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:08:01Z","timestamp":1789974481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-05184-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["5184"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05184-y","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no financial or commercial conflict of interest.","order":1,"name":"Ethics","label":"Conflict of iInterest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"653"}}